Core and Group Health

Fifty nine percent of patients will pay between $501 and $1,000 for a health care visit.

Under current benefits schedules, rising Social Security and Medicare costs will drive massive deficits.

A newly unredacted complaint appears to show several Big Pharma companies conspiring to fix prices.

The issue of coverage is no longer as simple as defining “marijuana and marijuana derivatives” and either excluding or covering them.

Hundreds of employers now include stem cell therapy in their insurance coverage, but is it worth the cost?

Addressing social barriers to health has become a priority for AHIP, leading to the launch of a new initiative, Project Link.